GRIN2A - focal epilepsy and speech disorder with or without intellectual disability

This test is available for the following conditions:

  • Conditions > Multiple congenital anomalies (MCA) > Epilepsy with neurodevelopmental defects (EPND)
  • Conditions > Neurological > Epilepsy with neurodevelopmental defects (EPND)

This product is also part of the following panels:

  • Epilepsy panel
  • Intellectual disability panel with genome wide CNV analysis
  • Mendelian inherited disorders panel with genome wide CNV analysis

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 138253
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 452

Gene

GRIN2A - focal epilepsy and speech disorder with or without intellectual disability

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 452

GRIN2A - focal epilepsy and speech disorder with or without intellectual disability



€ 452